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Abstract
Background: There is consensus that the treatment of schizophrenia should combine anti-psychotic medication
and psychosocial interventions in order to address complex social, economic and health needs. It is recommended
that family therapy or support; community-based rehabilitation; and/or self-help and support groups should be
provided for people with schizophrenia in low and middle-income countries. The effectiveness of community-based
psychosocial interventions in these settings is unclear.
Methods: Studies evaluating community-based psychosocial interventions for people with schizophrenia were
identified through database searching up to April 2016. Randomised controlled trials were included if they compared
the intervention group with a control group receiving treatment as usual including medication. Only studies set in low
and middle-income countries were included. Random effects meta-analyses were performed separately for each
intervention type.
Results: Eleven randomised controlled trials in five middle-income countries were identified, with a total of 1580
participants. The content of included interventions varied from single-faceted psychoeducational interventions, to
multi-component rehabilitation-focused interventions, to case management interventions. A third of the included
studies did not incorporate any community involvement in the intervention. The quality of evidence was often low.
Amongst the seven studies that reported on symptom severity up to 18 months post intervention, the pooled
standardised mean difference (SMD) across all intervention types was 0.95 (95% CI 0.28, 1.61; P 0.005; I 2 = 95%;
n = 862), representing a strong effect. A strong effect on symptom severity remained after excluding two studies with
a high risk of bias (SMD 0.80; 95% CI 0.07, 1.53; P 0.03; I 2 = 94%; n = 676). Community-based psychosocial interventions
may also have beneficial impacts on functioning (SMD 1.12; 95% CI 0.25, 2.00; P 0.01; I 2 = 94%; n = 511) and reducing
hospital readmissions (SMD 0.68; 95% CI 0.27, 1.09; P 0.001; I2 = 33%; n = 167).
Conclusion: The limited evidence from low and middle-income countries supports the feasibility and effectiveness of
community-based psychosocial interventions for schizophrenia, even in the absence of community mobilisation.
Community-based psychosocial interventions should therefore be provided in these settings as an adjuvant service in
addition to facility-based care for people with schizophrenia.
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Background
Provision of anti-psychotic medication alone is
inadequate to address the complex social, economic and
health needs of those affected by a chronic and highly
disabling illness such as schizophrenia. There is there-
fore consensus that the treatment of schizophrenia
should combine anti-psychotic medication and psycho-
social interventions [1–4]. Drug treatments generally
have most effect on positive symptoms, as well as being
effective at preventing relapse [5]. The relative inefficacy
of anti-psychotic medication in improving functioning
or negative symptoms [6] means a broader supportive
approach focused on rehabilitation is also required.
Furthermore, the balanced care model proposes that
mental health systems should include both community
and hospital-based care [7]. Psychosocial interventions
typically align with the principles of personal recovery,
such as the attainment of a fulfilling and valued life [8].
The Schizophrenia Patient Outcomes Research Team
(PORT) evidence-based recommendations, developed in
the United States, include eight psychosocial interven-
tions, all of which are recommended as an adjunct to
pharmacotherapy: assertive community treatment,
supported employment, cognitive behavioural therapy,
family-based services, token economy, skills training, and
psychosocial interventions for alcohol, substance use
disorders and weight management [9]. The strongest
evidence is for intensive case management (which has
evolved from assertive community treatment) [10], family
interventions [11] and psychoeducation [12], with possible
impacts on functioning, hospitalisations and relapse rates.
However, the quality of evidence is generally low across all
types of psychosocial interventions and until recently few
studies had been conducted in low and middle-income
countries (LMIC). It has also been noted that few of the
recommended interventions have been implemented at
scale, even in high-income countries [2].
The vast majority of people with mental illness in
LMIC do not have access to evidence-based treatments.
This is due to chronic underinvestment and a severe
shortage of mental health facilities and specialists [13].
Many LMICs are making important strides towards
improving care for people with mental illness, in particu-
lar through the integration of mental health into primary
care [14]. One of five priority Grand Challenges for
global mental health is to “Provide effective and afford-
able community-based care and rehabilitation”, giving
recognition to the substantial impact on disease-burden
reduction and equity this approach is likely to have, as
well as the likely immediacy of impact, and feasibility
[15]. However it is broadly accepted that a narrower
group of psychosocial interventions for schizophrenia
are likely to be feasible in LMIC compared to high-
income countries. The third edition of the World Bank’s
Disease Control Priorities (DCP-3) recommends that
family therapy or support; community-based rehabilitation
(CBR); and self-help and support groups should be priori-
tised in these settings [1]. These interventions may ad-
dress key challenges to the implementation of
psychosocial interventions for schizophrenia in LMIC.
First, they may be delivered by non-specialist workers, in-
cluding nurses without psychiatric training, lay health
workers and peer support workers, who are increasingly
regarded as the most scalable providers of both pharma-
cological and psychosocial treatments for schizophrenia in
LMIC [16]. This task shifting of mental health care is advo-
cated as a central approach for addressing the shortage of
mental health specialists, and ultimately the treatment gap,
present in these settings [17]. Second, these interventions
may address the broader social and livelihood needs of ser-
vice users in LMIC. In Ethiopia functional impairment in
people with schizophrenia has been conceptualised as aris-
ing from severe poverty as much as psychotic symptoms
[18]. Some psychosocial programmes in LMIC use an expli-
cit ‘mental health and development’ model focused on eco-
nomic empowerment [19]. Tailored approaches to mitigate
human rights abuses, such as physical restraint, may also be
required [20]. CBR places particular emphasis on commu-
nity involvement, which may entail awareness-raising or
mobilisation of practical support from community members.
Community mobilisation is seen as the lynch-pin of creating
sustainable CBR programmes [21]. Some commentators
have cautioned against exporting ‘Western’ diagnoses of
mental disorders to settings that have traditionally used al-
ternative explanatory models and labels for distress or dis-
turbed behaviour [22]. It has also been argued that the scale
up of biomedical services could marginalize faith and trad-
itional healing [23]. However there have been several suc-
cessful cultural adaptions of psychosocial interventions
across settings and mental disorders [24, 25].
Whilst there is increasing evidence of the acceptability
and feasibility of various modalities of community-based
psychosocial interventions for schizophrenia in LMIC
[26], evidence of effectiveness has been lacking. Given
the differences in mental health infrastructure and needs
of service users in these settings, a systematic review
focused on LMIC is indicated. A systematic review
conducted in 2012 by Iemmi et al. identified 15 con-
trolled studies of CBR for a range of physical and mental
disabilities. Iemmi et al. reported that overall CBR had a
modest positive impact on people with mental disabil-
ities including dementia, schizophrenia and intellectual
impairment. However they highlighted the poor quality
and non-randomised design of many of the included
studies [27]. An initial scoping search undertaken in
April 2016 indicated that additional relevant randomised
studies had been published since the Iemmi et al. review
was conducted. This suggested that an updated review
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would be of value. Furthermore, the scope of the review
was broadened beyond CBR to all community-based
psychosocial interventions for schizophrenia. The aim of
this review was to assess the effectiveness of all types of
community-based psychosocial interventions for people
with schizophrenia on patient outcomes in LMIC.
Methods
Systematic literature search
Eligibility criteria
Individual and cluster randomised controlled trials were
included. Eligible interventions were any community-
based psychosocial intervention delivered to people with
schizophrenia or their caregivers with the aim of
improving patient outcomes (see Additional file 1).
Studies set in urban and rural locations were included.
Psychosocial interventions were defined as any interven-
tion that focused on psychological and/ or social factors
rather than biological factors (for example a pharmaco-
logical intervention). Interventions could have one or
multiple components. Community-based interventions
were defined as any intervention delivered in the partici-
pant’s home or another community setting. Interven-
tions that took place exclusively in health or other
institutional facilities (hospitals, clinics, outpatient care
centres or specialised care centres) were excluded.
Papers without a full text available in English were
excluded due to logistical constraints.
Information sources
Database searches were carried out on the 18th and
19th April 2016. The following databases were searched:
Medline, EMBASE, PsycINFO, Global Health, CINAHL
and Africa Wide information. In addition the Cochrane
Library was searched for relevant systematic reviews.
The included studies list of each relevant Cochrane
review was searched for additional references not already
identified in the previous database searches. The
Clinicaltrials.gov database was searched for relevant
trials; for all trials identified, a search was carried out for
relevant linked publications on the clinicaltrials.gov
database and on PubMed. The websites of organisations
known to conduct relevant research projects and pro-
gammes, including BasicNeeds, CBM, and Sangath, were
searched for relevant reports and studies. All innovation
entries on the Mental Health Innovations Network
(MHIN) database were reviewed for relevance and
linked publications were sought on PubMed. MHIN is
an online platform and database for sharing knowledge,
experiences and resources relating to global mental
health (www.mhinnovation.net). Reports and guidelines
relating to mental health and development or CBR were
reviewed for relevant programmes, including the World
Health Organisation’s (WHO) CBR guidelines [21],
WHO report on Mental Health and Development [28] and
the UK government Mental Health for Sustainable Devel-
opment Report [29]. Relevant literature reviews relating to
CBR [27], psychosocial interventions [26, 30], task-sharing
[17, 31] and packages of care [1, 2, 32] for mental illness in
LMIC were also reviewed for relevant references.
Search strategy
The search identified studies covering four domains: A:
Schizophrenia or schizoaffective disorder + B: community-
based psychosocial intervention + C: low or middle-income
country + D: randomised controlled study. Additional file 2
presents the search strategy that was designed for Medline;
minor modifications were made as required for other
databases. A broad range of search terms were used for
domain B, including terms relating to psychoeducation,
adherence support, family support, rehabilitation, psycho-
therapy and counselling, self help groups, health promotion
and community-based care. For domain C, separate terms
were included for each LMIC, along with generic terms
such as ‘developing country’.
Study selection
The results of all database searches were downloaded to
Endnote X7. Duplicates were removed and the titles and
abstracts of the remaining records were screened for
relevance. The full texts of those deemed to be relevant
were acquired and reviewed. A final list of included
eligible studies was compiled after reviewing the full text.
Data extraction and quality assessment
Key features and findings of each included study were
extracted onto a specially designed database. Data were
extracted on study characteristics (setting, design, num-
ber of participants randomised and duration of follow
up), inclusion criteria, characteristics of the interven-
tions (content, frequency and duration) and outcomes.
The Cochrane Collaboration risk of bias tool was used
to assess each included study [33]. A rating of low, high
or unclear risk of bias was given for the following
domains: sequence generation; allocation concealment;
masking of assessors; selective outcome reporting;
incomplete data and other source of bias. Blinding of
participants and workers delivering the intervention was
not possible due to the nature of the interventions,
therefore this criterion was not used.
Statistical analyses were performed using Review
Manager 5.3 for Mac. For outcomes measured on con-
tinuous scales, the post-treatment mean and standard
deviation in the intervention and control groups were
extracted along with the sample size in each group.
Where these data were presented in the paper, the infor-
mation was used to calculate the standardised mean
difference (SMD) for each trial in order for different
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outcome scales to be pooled. SMD is a summary statistic
that represents the size of the intervention effect in a study
relative to the variability observed in that study. The follow-
ing cut offs were used to guide interpretation of the
strength of effect: 0.2 represents a “small” effect, 0.5 repre-
sents a “medium” effect, and 0.8 represents a “large” effect
[34]. Due to absence of relevant data in the included
papers, it was not possible to take into account differences
in baseline scores between treatment groups, in the calcula-
tion of SMD. Where outcomes were presented as propor-
tions, risk ratios were calculated. For any scale where an
increase in score indicates worse outcome, mean scores or
proportions were inverted before calculating the SMD or
risk ratio. Acknowledging the heterogeneity in interven-
tions, random effects meta-analyses were performed with
all intervention types together along with subgroup meta-
analyses for each intervention type separately. Meta-
analyses were also performed separately for outcomes mea-
sured less than 18 months after the intervention ended and
outcomes measured more than 18 months after the inter-
vention ended. Heterogeneity between trials was assessed
using the I2 statistic. In order to understand the impact of
study quality on the findings, a sensitivity analysis was
conducted excluding studies perceived to have the highest
risk of bias overall; these studies comprised those with a
risk of bias for allocation concealment, or, for those with an
unclear risk of bias for allocation concealment, those
studies with a risk of bias for sequence generation or
masking of outcome assessment [30]. Lastly, a funnel plot
for symptom severity (the outcome utilised by the most
studies (n = 7)) was generated to assess for publication bias.
Results
Overview
From 9543 records, 13 records reporting 11 studies met
inclusion criteria for the review (see Fig. 1). The reasons for
excluding full text articles are presented in Additional file 3.
Study characteristics
Overview
Table 1 gives a summary of the features of the intervention
and study design for each included study. Across all included
studies there were a total of 1580 participants with a median
sample size of 101, ranging from 45 to 326. Five studies,
reported in six papers, were conducted in China [35–40],
two studies were conducted in India [41, 42] and Iran [43,
44], one study, reported in two papers, was conducted in
South Africa [45, 46], and one study was conducted in
Turkey [47]. All studies were conducted in upper-middle
income countries apart from the two studies based in India,
which is classified by the World Bank as lower-middle
income. There were no studies conducted in low-income
countries. Five studies took place in urban areas [37, 43–47],
two were exclusively in rural areas [35, 36, 38] and one was
set across urban and rural sites [41]. The study location was
not indicated in three studies [39, 40, 42].
Home-based care components
All interventions included a home-based element, a
psychoeducation component, and in all studies the inter-
vention group also had access to psychotropic medication.
Only the South African study by Botha et al. did not
explicitly refer to family involvement in the intervention
delivery [45, 46]. Aside from these factors the content and
structure of interventions varied between studies. Three
broad groups were identified, but with considerable over-
lap between groups and variation within groups. Group A
consisted of largely single-faceted psychoeducation inter-
ventions, including three Chinese studies, Li 2005, Xiang
1994 and Zhang 1994 [37–39], and one Indian study,
Hegde 2012, that provided cognitive retraining alongside
psychoeducation [42]. Group B consisted of more
comprehensive multi-faceted interventions including
components such as family intervention, support develop-
ing social and independent living skills, medication adher-
ence support, crisis intervention and dealing with stigma.
This group included the Indian COPSI community-based
care trial, Chatterjee 2014 [41], and two Chinese RCTs,
Cai 2015 and Ran 2015 [35, 36, 40]. Group C comprised
studies focusing on engagement with care following dis-
charge from inpatient facilities, alongside other elements
such as social skills training. In this group the South
African study, Botha 2014, was based on an assertive com-
munity treatment model [45, 46], whilst two Iranian
RCTs, Sharifi 2012 and Ghadiri 2015, assessed home-
based aftercare services [43, 44], and a Turkish RCT,
Sungur 2011, evaluated optimal case management [47].
All Group C studies were based in urban areas.
Community involvement components
In five studies, in South Africa, India, Iran and Turkey,
individuals were supported to access community resources
and organisations including legal benefits, employment
opportunities, and non-governmental organisations (NGO)
[41, 43–47]. Two Chinese studies, Xiang 1994 and Ran
2015, conducted awareness-raising about mental illness
through local radio stations [35, 36, 38]. Four interventions
did not include any community engagement or facilitation
of support outside of the home-based intervention [37, 39,
40, 42]. Aside from referring to existing community agen-
cies, no studies incorporated active involvement of commu-
nity members to support individuals with schizophrenia.
Personnel
The primary personnel delivering the intervention varied
between studies. In three studies, professionals not
specialised in mental health, such as social workers or
nurses, were the main personnel [37, 44–46]; and in two
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studies care was delivered by mental health profes-
sionals, such as psychiatrists [35, 36, 47]. Only in one
study, Chatterjee 2014, was the intervention delivered
by lay community health workers [41]. In all but one
study the lay community workers and non-mental
health professionals worked in a collaborative care
model with specialist input [41, 44–46]. In five
studies the professional background of the person
delivering the intervention was unspecified or unclear
[38–40, 42, 43]; the presence of specialist supervision
was also not specified in these studies. Interventions
were delivered for a median period of 12 months
(range 10 weeks to 24 months). The evaluation was
conducted immediately on the intervention terminat-
ing for six studies and between 6 months to 13 years
after the intervention ended for the remaining five.
Comparison
Six studies compared the intervention to treatment with
medication provision only (typically delivered in an
outpatient clinic) and no psychosocial support [37–40,
43, 44]; two studies, Chatterjee 2014 and Hegde 2012,
specified that the control included both medication and
psychoeducation in an outpatient setting [41, 42]; and
the South African and Turkish case management stud-
ies, Botha 2014 and Sungur 2011, used outpatient care
delivered by a community mental health team as a
control [45–47]. One of the Chinese family intervention
studies (Ran 2015, Group B) consisted of three arms,
comparing (i) a psychoeducational family intervention
and medication (ii) medication only and (iii) no inter-
vention and medication neither encouraged or discour-
aged [35, 36]. In this review only the intervention effects
Fig. 1 Flow chart of study selection process
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comparing the family intervention and the medication
only arm are presented.
Outcomes assessed
A wide range of outcomes were assessed including
symptoms or clinical state (all studies), functioning
(eight studies), medication adherence (four studies),
number of hospitalisations (four studies), quality of life
(three studies), knowledge about schizophrenia (three
studies), depression (two studies), family burden (two
studies), cognitive function (two studies), length of hos-
pital stay (two studies), and stigma and discrimination
(one study). Clinical symptoms were measured with the
Positive and Negative Syndrome Scale (PANSS), the
Brief Psychiatric Rating Scale, the mania rating scale and
the Current Psychiatric Status-50. Functioning was mea-
sured with the Social and Occupational Functioning As-
sessment Scale, the Social Disability Screening Schedule,
the Global Assessment of Functioning, the Global Assess-
ment Scale, the Indian Disability Evaluation Assessment
Scale (IDEAS) and ‘working ability’. Depression was mea-
sured using the Hamilton Rating Scale for Depression and
the Calgary Depression Scale. Quality of life was measured
with the WHOQOL (Quality of Life)- BREF and the Qual-
ity of Life Scale. Caregiver burden was assessed with the
Burden Assessment Schedule and the Scale for the Assess-
ment of Family Distress.
Participants and design
There were some differences in diagnoses across studies,
with seven studies including only participants with
schizophrenia [35–37, 39–42, 47], one study including
participants with schizophrenia or schizoaffective
disorder [45, 46] and three studies including participants
with schizophrenia, schizoaffective disorder or bipolar
disorder [38, 43, 44]. Nine studies used an individually
randomised design [38–47], whilst two studies used a
cluster randomised design [35–37]. Three studies were
conducted across multiple sites [38, 40, 41].
Risk of bias
Overall studies were of low to moderate quality. A sum-
mary of the risk of bias for each included study is pre-
sented in Additional file 4. Ghadiri 2015, Sharifi 2012,
Hegde 2012 and Li 2005 were rated as having a high
overall risk of bias [37, 42–44]. Hegde 2012 was
excluded from the synthesis of results due to the high
risk of bias and the very low sample size included in the
outcome analysis (n = 12 in treatment group, n = 11 in
control group) [42]. The findings of Sharifi 2012 are not
included in the meta-analysis due to incomplete data
presented in the paper (no denominator is given for out-
come data). Allocation concealment was adequately
described in only one study, whilst procedures were
unclear in ten studies. Five studies were assessed to have
a high risk of outcome assessors being unblinded, with
two studies having a low risk and four studies having an
unclear risk. The risk of bias in relation to selective
reporting was difficult to assess in seven studies, whilst
one study (which had a published protocol [48]) was
assessed as low risk and three studies were assessed as
high risk (one of which had a published protocol [49]).
Synthesis of results
Symptoms and clinical status
Amongst the seven studies that reported on symptom
severity <18 months post intervention the pooled SMD
across all intervention types was 0.95 (95% CI 0.28, 1.61;
P 0.005; I 2 = 95%; n = 862), representing a strong effect
(see Fig. 2). Excluding the two studies with a high risk of
bias reduced the effect size (though this remained
‘strong’), and the precision of the estimate decreased
(SMD 0.80 (95% CI 0.07, 1.53; P 0.03; I 2 = 94%;
n = 676)) (see Additional file 5).
Ran 2015 also reported on long-term symptom severity,
finding no difference between treatment arms at 14 years
follow-up [35] (SMD 0.16 (95% CI -0.15, 0.47; P 0.3;
n = 165) comparing the experimental arm and medication
control arm). There was some indication that Group B
interventions (multi-component rehabilitation interven-
tions) were less effective at reducing symptoms compared
to Group A (psychoeducation focused) and Group C (case
management) interventions. However this apparent find-
ing should be viewed with caution given the overlaps
between intervention type. All four Group C studies (in-
cluding Sharifi 2012 [44], which was excluded from the
meta-analysis due to insufficient data) found a strong as-
sociation with improvements in symptoms. Whereas, in
Group B, Cai 2015 [36] and Chatterjee 2014 [41] did not
find a statistically significant difference in symptom sever-
ity between treatment arms. There was no clear indication
that urban or rural location was associated with a greater
impact on symptoms. Whilst all urban-based interven-
tions were effective at reducing symptoms [43–47],
Chatterjee et al. found that community-based care led to a
reduction in symptoms in rural, but not urban, areas [41].
Functioning
Amongst the five studies that assessed functioning
<18 months post-intervention using a continuous scale,
the pooled SMD across all intervention types was 1.12
(95% CI 0.25, 2.00; P 0.01; I 2 = 94%; n = 511), represent-
ing a strong effect (see Fig. 3). All studies in this group
were high quality so a sensitivity analysis was not con-
ducted. However, the pooled results of the two studies
that measured the proportion able to work <18 months
post-intervention did not show an association; the
pooled risk ratio was 1.09 (95% CI 0.85, 1.40; n = 306)
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(see Additional file 5). One of these studies, Ran 2015,
also measured functioning and work ability after 14 years,
but did not find an effect. Comparing the experimental
arm and medication control arm, they found an SMD of
0.16 (95% CI – 0.15, 0.47; P 0.3; n = 165) for functioning
and a risk ratio of 1.13 (95% CI 0.93, 1.36) for work abil-
ity [35]. Once again the Group B interventions appeared
to have the least effect on functioning and work ability.
Chatterjee 2014, a Group B study, found a small effect
on functioning, though reductions in disability were
more prominent in the rural site compared to the two
better-resourced urban sites [41].
Readmissions and inpatient days
Two Group C (case management) studies, Botha 2014
and Ghadiri 2015, reported on the number of readmis-
sions and number of days in hospital <18 months post
intervention. The pooled SMD for number of readmis-
sions was 0.68 (95% CI 0.27, 1.09; P 0.001; I2 = 33%;
n = 167) and the pooled SMD for number of days in
hospital was 0.55 (95% CI 0.24, 0.86; P 0.0006; I2 = 0%;
n = 167), both representing a medium intervention
effect (see Additional file 5). The intervention effects
remained when Ghadiri 2015, which had a high risk of bias,
was excluded. Zhang 1994 (Group A: psychoeducation) also
Fig. 2 Community-based psychosocial intervention versus usual care: impact on symptom severity (<18 months post intervention)
Fig. 3 Community-based psychosocial intervention versus usual care: impact on functioning (<18 months post intervention)
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found a positive intervention effect on the proportion with
no hospital readmissions over the 18-month period of the
intervention (risk ratio 1.83; 95% CI 1.27, 2.64; n = 51).
Botha 2014 [45] also reported on outcomes at 2 years after
the intervention terminated. They found a strong effect on
readmissions (SMD 0.96; 95% CI 0.40, 1.52; P 0.0008;
n = 56) and a medium effect on days in hospital (SMD 0.75;
95% CI 0.20, 1.30; P 0.007). It is difficult to determine if
Group C (case management) interventions confer any
advantage over other types of interventions in reducing
readmission rates, as this outcome was not measured for
any Group B studies and only one Group A study.
Medication adherence
Two group A (psychoeducation) and two group B (multi-
component rehabilitation intervention) studies reported on
the proportion of participants who were adherent to medi-
cation. There was a borderline significant effect including
all studies (risk ratio 1.24; 95% CI 0.97, 1.57; P 0.09; I2 55%;
n = 648) (see Fig. 4). However the precision of this effect
was reduced with the exclusion of Li 2005, which had a high
risk of bias (risk ratio 1.33; 95% CI 0.90, 1.97; P 0.16;
I2 = 70%; n = 557) (see Additional file 5). No studies
assessed the long-term impact on medication adherence.
Other outcomes
Three Group C (case management) studies reported on
quality of life outcomes. Botha 2015 and Sharifi 2012
reported that there was no observed impact on quality
of life but did not present the relevant data [44, 46].
However Sungur 2011 found a strong intervention effect
on quality of life (SMD 2.05; 95% CI 1.53, 2.57;
P < 0.001; n = 89) [47].
Of the two studies that reported caregiver burden,
only Sungur 2011 found an effect (SMD 2.50; 95% CI
1.93, 3.06; P < 0.001) [47]. No impact on family burden
was observed in Chatterjee 2014 (Group B); insufficient
data were provided to calculate the SMD [41].
Two studies, Li 2005 (Group A) and Ran 2015 (Group B),
reported significant improvements in knowledge and beliefs
about schizophrenia [36, 37]. Li 2005 found a strong inter-
vention effect (SMD 1.04; 95% CI 0.54, 1.55; P < 0.001;
n = 69). Ran 2015 reported favourable differences between
treatment arms for six out of eight individual items covering
caregiver beliefs and knowledge [36]. No impact on know-
ledge was observed in Chatterjee 2014 (Group B) (adjusted
mean difference 0·34; 95% CI −0·28, 0·96; insufficient data
were provided to convert to SMD) [41]. Chatterjee et al.
(Group B) were the only study to evaluate the impact on
stigma and discrimination; they did not demonstrate an
intervention effect [41].
Publication bias
A funnel plot of symptom severity showed some asym-
metry (see Additional file 6). This may indicate that
smaller studies without statistically significant effects
have not been published.
Discussion
Summary of findings
Overall community-based psychosocial interventions in
LMICs have a strong effect on symptom severity in
people with schizophrenia. There was also evidence of a
strong effect on functioning and a medium effect on
reducing hospital readmissions, though fewer studies
measured these outcomes. These findings were consist-
ent with the 2012 systematic review of CBR by Iemmi
Fig. 4 Community-based psychosocial intervention versus usual care: impact on medication adherence (<18 months post intervention)
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et al. [27], but were arguably more robust given the
inclusion of eight further RCTs [37, 38, 40–44, 47]. In
addition, follow up studies [35, 45] were included of two
of the three RCTs relating to schizophrenia that were part
of the previous review.
Whilst in some cases there was a substantial impact
on outcomes, in other studies such as Chatterjee 2014
the overall impact was slight. However this magnitude of
impact may be no different than community-based pro-
grammes in high-income countries, and a greater effect
was seen in rural areas with fewer resources [41]. There
was evidence from only one study, of assertive commu-
nity treatment in South Africa [45], that positive effects
could endure for two years after the intervention termi-
nated. Most studies did not evaluate ongoing effects.
Much of the evidence was judged to be of low or unclear
quality, meaning conclusions about the effectiveness of
these interventions should be made with caution.
The nature of usual care, which differed considerably
between studies in this review, should be taken into
account when assessing the strength of the evidence. In
evaluations where usual care is comprehensive (for
example medication, psychoeducation and adherence
support offered by psychiatrists in Chatterjee 2014 [41]),
smaller gains may be expected from the provision of an
adjuvant intervention, compared to evaluations with a
low level of usual care (for example medication only in
the Chinese psychoeducation-focused RCTs [37–39]).
Chatterjee et al. also pointed to the greater impact on
disability seen amongst the sub-group who had not
previously had access to high-quality facility-based care,
compared to those who had [41]. However this suppos-
ition does not necessarily hold true; for example Sungur
2011 had large effect sizes yet had one of the most com-
prehensive packages of usual care (outpatient-based case
management) [47].
Several possible mechanisms for the impact of
community-based psychosocial interventions present
themselves. Supported engagement with treatment
and an improved understanding about the nature of
the illness and role of medication, by both caregivers
and the person with schizophrenia, may lead to
improved medication adherence. This in turn may re-
sult in improved symptoms and therefore lower re-
lapse rates and fewer hospitalisations. Chatterjee et al.
reported a trend towards improved symptoms with
improved medication adherence [41], a pattern that
has been identified in cohort studies in other LMICs
[50]. However only four studies included in this re-
view assessed medication adherence and overall there
was a borderline intervention effect. The challenges
of intervening to improve medication adherence have
been noted across all settings and are not exclusive to
mental disorders [51].
It is striking that all types of interventions, including
psychoeducation on its own, produced a positive effect
on functioning. This may be due to an improvement in
symptoms. Other possible pathways to improved func-
tioning are through the impact of improved social skills,
improved self-esteem, greater caregiver support, reduced
self-stigma or discrimination, or an increased sense of
empowerment. However there was almost no assessment
of these potential intermediary factors in the included
studies. Where the outcomes of quality of life, family
burden and perceived stigma were reported, there was
less evidence for a beneficial effect of community-based
psychosocial interventions.
Strengths and limitations
Strengths of this study include the inclusive inclusion
criteria with respect to intervention content and the
robust assessment of study quality. Capturing and
synthesising the results of all relevant studies that share
the core elements of home-based psychoeducation for
schizophrenia in LMICs is a strength of this review.
However, the interventions varied considerably in terms
of content, intensity, duration and delivery personnel.
While the interventions were divided into sub-groups
for the meta-analysis, there was variation within groups
and overlap between groups.
Whilst the search strategy captured the spectrum of inter-
vention content that may be defined as a community-based
psychosocial intervention, rehabilitation programmes based
in specialist centres (e.g. [52]) were excluded. This was ar-
guably an unhelpful division, which would not reflect the
integrated programming and delivery of psychosocial inter-
ventions for schizophrenia in many settings. Outpatient-
clinic based psychosocial interventions also represent an
important component of services for people with mental
illness in LMIC [7]. There is a growing evidence base for
such interventions (e.g. [53, 54]) that also requires system-
atic review. Other methodological limitations of this review
include the single screening of records and exclusion of
reports not published in English.
Implications
The results of this review suggest that in LMIC a
community-based psychosocial intervention should be
provided in addition to facility-based care for people
with schizophrenia. Such interventions may have a
tangible impact on clinical outcomes. To date there has
been limited implementation of psychosocial interven-
tions for schizophrenia in LMIC. The most successful
examples of implementation at scale are found in
middle-income countries [49, 55]. China’s nationwide
‘686’ programme, which includes active community case
finding, community-based care (including multi-
disciplinary team input) and hospital care, had achieved
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30% coverage of the whole population by 2011 [55]. In
low-income countries, whilst community-based psycho-
social interventions have been delivered on a small scale
by NGOs such as BasicNeeds [19, 56], there are fewer
examples of large scale delivery within government run
health services [57]. Implementation may vary between
low and middle-income settings due to differences in
mental health infrastructure and specialists, which are in
turn shaped by government prioritization and funding.
The included studies from upper middle-income countries
tended to take place in the context of well-established
inpatient and outpatient mental health facilities [43, 45].
In many low-income countries, mental health care is not
available even at the primary care level, let alone at a
secondary or tertiary level [58]. The median number of
psychiatrists is 0.05 per 100,000 population in low-income
countries and 0.54 per 100,000 in lower middle income
countries, compared to 2.03 per 100,000 in upper middle
income countries and 8.59 per 100,000 in high income
countries [13]. This corresponds to a much larger treat-
ment gap for schizophrenia in low-income countries
(89%) compared to lower-middle-income (69%) and
upper-middle-income countries (63%) [59]. An absence of
facility-based care, including provision of anti-psychotic
medication, is likely to be a fundamental barrier to provid-
ing adjuvant psychosocial support.
Whilst some of the included studies discussed the
feasibility and relevance of the intervention for local
health systems and other LMICs [41, 45], for many stud-
ies it was not clear how or whether interventions could
be integrated [37, 40]. Future research should be cogni-
sant of the wider health system, as well as the broader
social and economic setting. Most of the included inter-
ventions were delivered by health care workers, and in
some cases by mental health specialists. This is likely to
reflect the upper middle-income setting of nearly all
included studies. Even in the COPSI trial, Chatterjee
2014, in which community-based support was delivered
by lay health workers, participants received care from
psychiatrists in parallel [41]. These interventions,
particularly those involving multi-disciplinary teams,
may not be feasible in most low-income countries. Mov-
ing forward, RCTs of community-based psychosocial in-
terventions are needed in low-income settings, where
due to a shortage of human resources the most appro-
priate personnel are likely to be non-specialist or lay
workers [60]. In this review there were no clear indica-
tions that interventions delivered by non-mental health
specialists resulted in different outcomes compared to
those delivered by mental health specialists. This finding
strengthens calls for mental health interventions deliv-
ered by non-specialists to be prioritised in LMIC, on the
basis that they are effective [17] as well as feasible and
acceptable [31].
When evaluated in RCTs community-based psycho-
social interventions appear to be as effective, or more
effective [41], in rural compared to urban settings. How-
ever, when implemented at larger scale practical barriers
to home-based care delivery may arise, due to the large
distances between households and lack of public trans-
port [61]. The need to assess the impact of these
feasibility concerns is a compelling rationale for large
scale implementation studies.
Another gap in the evidence relates to the scope of
interventions. All interventions in this review focused
mainly on health issues, with only some touching on
social and livelihood elements through skills training.
Furthermore there was little emphasis on community
mobilisation, beyond the awareness-raising component
mentioned in two studies. Where the intervention
involved signposting to community resources, there was
no detail on whether or how participants accessed these
resources. These broader community mobilisation and
rehabilitation components form some of the key ele-
ments of CBR, which is recommended as an appropriate
approach for LMIC. As there is some evidence for the
effectiveness of the included studies without these
broader components, it is arguable that these elements
are not required to achieve improvements in patient out-
comes. However it is possible that in low-income set-
tings with few formal health resources, no social security
and where the impact of inability to work may be more
profound, broader efforts to draw on local community
resources and to address livelihood issues may have
more relevance.
All included studies assessed symptoms or clinical
state, eight studies evaluated the impact on functioning
and four assessed mental health service use. Whilst this
broadly aligns with outcome measures typically used in
similar evaluations in high-income countries [12, 62, 63],
recent RCTs have focused on user satisfaction with care
[64] and personal recovery [65] as primary outcomes.
Personal recovery may also be a pertinent outcome for
LMIC countries, however further work is needed to
understand the cross-cultural applicability of this con-
cept. To our knowledge only one study, Chatterjee 2014
[41] used a functioning scale specific to the country con-
text. It is proposed that locally adapted functioning
scales for psychosis in LMIC offer a more valid measure
of disability [66]; such scales should be used wherever
possible in future evaluations. A further candidate out-
come for LMIC is family-level economic impact, given
the important influence of poverty on illness experience
in low-income settings [18] and the potential inclusion
of livelihood support in psychosocial interventions.
Only three studies assessed outcomes of between
6 months and 13 years after the interventions had termi-
nated [35, 37, 40]. Such study designs, which give
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valuable information on how to shape psychosocial
interventions for scaling up, should be utilised where
possible in future research. Of the eleven included stud-
ies, only Chatterjee 2014, is known to have conducted
in-depth intervention development and piloting in
advance of the full evaluation [67]. Formative work is
essential to ensure interventions are culturally appropri-
ate and acceptable for the setting, for example by
acknowledging local explanatory models or involving
faith and traditional healers in the intervention [61].
Chatterjee 2014 also collected process data [41] and
conducted a qualitative analysis alongside the trial [68].
For multi-component interventions, theoretical frame-
works for the process of change need to be developed to
understand which elements contribute towards any
impact seen, and why certain elements do or do not
contribute to positive effects for participants [69]. Full
process evaluations, as well as parallel qualitative studies,
are likely to be required. This is particularly pertinent in
low-resource settings where low-intensity interventions,
employing only the most effective components, may be
more feasible for implementation at scale. Alongside a
general need for high quality evaluations of community-
based psychosocial interventions for schizophrenia, fu-
ture studies also need to identify and evaluate intermedi-
ate outcomes to better understand the mechanisms
through which these interventions achieve their impact.
Economic evaluations are also needed.
Conclusion
The limited evidence from low and middle-income coun-
tries supports the feasibility and effectiveness of community-
based psychosocial interventions for schizophrenia, even in
the absence of community mobilisation. Community-based
psychosocial interventions should therefore be provided in
these settings as an adjuvant service in addition to facility-
based care for people with schizophrenia.
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